Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Whitney McKnight

    Article

    December 2017: Click for Credit

    Author:
    Kari Oakes
    Mitchel L. Zoler, PhD
    Gina Henderson
    Doug Brunk
    Whitney McKnight

    Topics include: Recurrent strep throat • Motivational pharmacotherapy for minority patients with depression • Revised Bethesda System thyroid...

    • Read More

    News

    IV ketamine proves superior to active placebo in low, high doses

    Author:
    Whitney McKnight
    Publish date: August 14, 2017

    MIAMI – Researchers close in on a range of ketamine doses that could provide temporary relief for patients with treatment-resistant depression.

    • Read More

    News

    ‘Motivational pharmacotherapy’ engages Latino patients with depression

    Author:
    Whitney McKnight
    Publish date: August 14, 2017

    MIAMI – Delivering pharmacotherapy in a culturally sensitive way can help improve antidepressant adherence.

    • Read More

    News

    Continuous glucose monitors aren’t just for abdomens anymore

    Author:
    Whitney McKnight
    Publish date: August 8, 2017

    Personal photos of real-time continuous glucose monitors posted to online forums dedicated to diabetes management lead to questions about whether...

    • Read More

    News

    Senate confirms first mental health czar

    Author:
    Whitney McKnight
    Publish date: August 7, 2017

    Dr. Elinore F. McCance-Katz, a psychiatrist, is an expert in using pharmacotherapy for treating substance use disorders.

    • Read More

    News

    FDA approves faster, pangenotypic cure for hep C virus

    Author:
    Whitney McKnight
    Publish date: August 7, 2017

    A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.

    • Read More

    News

    FDA approves faster, pangenotypic cure for hep C virus

    Author:
    Whitney McKnight
    Publish date: August 4, 2017

    A faster cure for all genotypes of the hepatitis C virus with or without liver disease comes to market.

    • Read More

    Video

    VIDEO: What role does autoimmune dysfunction play in schizophrenia?

    Author:
    Whitney McKnight
    Publish date: August 4, 2017

    Researchers are studying the role autoimmune reactions such as inflammation play in the pathogenesis of schizophrenia, with and without comorbid...

    • Read More

    News

    More treatments becoming available for tardive dyskinesia

    Author:
    Whitney McKnight
    Publish date: July 26, 2017

    MIAMI – A second VMAT2 inhibitor may join Ingrezza as a safe and effective treatment for the movement disorder.

    • Read More

    News

    Expert: Engage patients, clinicians as partners in research

    Author:
    Whitney McKnight
    Publish date: July 17, 2017

    MIAMI – A new research paradigm treats every case as an N of 1 that could improve the care of millions.

    • Read More

    News

    VA/DOD elevate psychotherapy over medication in updated PTSD guidelines

    Author:
    Whitney McKnight
    Publish date: July 11, 2017

    MIAMI – Should trauma-focused psychotherapy supplant medication for first-line treatment?

    • Read More

    News

    Patients’ profile deemed best criteria for LAIs in bipolar disorder

    Author:
    Whitney McKnight
    Publish date: July 10, 2017

    MIAMI – Bipolar disorder patients with very severe illness, or who are at the more extreme spectrum in terms of risk, might not be receiving...

    • Read More

    News

    Reframe view of borderline personality disorder patients as survivors

    Author:
    Whitney McKnight
    Publish date: July 6, 2017

    WASHINGTON – Consider that patients with borderline personality disorder are wired for threats and can be helped by positive reinforcement, an...

    • Read More

    News

    First-episode psychosis is a ‘brain attack,’ and LAIs can prevent recurrence, expert says

    Author:
    Whitney McKnight
    Publish date: July 6, 2017

    Dr. Henry A. Nasrallah urges psychiatrists to start thinking of long-acting injectables as a tool to prevent relapse in patients experiencing...

    • Read More

    News

    Novel female sexual dysfunction drug effective, phase III studies show

    Author:
    Whitney McKnight
    Publish date: June 19, 2017

    Bremelanotide, which is administered subcutaneously, addresses low female sexual desire that is biological in nature.

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery